Study Highlights Results of 2 Dosing Regimens of Guselkumab on PsA Symptoms at 24 WeeksByTim SmithAugust 8th 2025The APEX study presents the results of 2 dosing regimens of guselkumab (Q4W and Q8W) in biologic-naïve patients with psoriatic arthritis (PsA).